Trial intelligence / Profile preview

Boric Acid Gel Adjunct to SRP in Chronic Periodontitis

NCT02903108Phase 3Completed

Sponsor
Government Dental College and Research Institute
Start
May 2015
Primary completion
Oct 2015
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in chronic periodontitis comparing Boric acid group with Placebo group (2 arms). Primary endpoint: Radiographic Defect Depth Reduction at 6 months. Started May 2015; status: completed.

02

Drugs

boric acid
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT02903108.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02903108.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call